Fuan Pharmaceutical(Group) Co.,Ltd.’s Net Profit Rose 87.1% in First Half of 2023

Fuan Pharmaceutical(Group) Co.,Ltd. (福安药业(集团)股份有限公司) (300194.SZ) reported a net profit of 164 million yuan in the first half of 2023, up 87.1% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 15.5% year-on-year.

At the end of the reporting period, it had 6.3 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 35.5%.